Viewing Study NCT01193595


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2025-12-26 @ 4:11 PM
Study NCT ID: NCT01193595
Status: COMPLETED
Last Update Posted: 2014-12-03
First Post: 2010-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module